PhylloTech, a US-based company, innovatively uses plants to produce cost-effective proteins and antibodies, offering rapid scalability and environmental sustainability.
PhylloTech, based in Madison, United States, innovatively uses a continuous plant expression system to produce cost-effective proteins and antibodies in the glandular secreting trichomes of Nicotiana tabacum. This method allows proteins to be secreted onto leaf surfaces for easy recovery, eliminating purification needs and reducing production costs. PhylloTech focuses on producing difficult-to-manufacture proteins and antibodies, emphasizing rapid scalability and environmental sustainability.
PhylloTech has made significant strides in biotechnology by leveraging plant-based systems for protein production, achieving notable cost reductions and efficiency improvements. The company's innovative approach has positioned it as a key player in the biotech industry, contributing to advancements in sustainable and scalable protein manufacturing.
